ATXI: Avenue Therapeutics, Inc. Forvard P/E multiplikatori

Avenue Therapeutics, Inc. - ATXI emitenti grafik logotipi

FDA bilan bog'liq tartibga soluvchi o'zgarishlar va tramadolga tegishli kechikishlar Avenue Therapeutics (ATXI) kompaniyasiga moliyaviy bosim o'tkazmoqda. Kompaniyaning oldingi P/E koeffitsiyenti likvidlik dinamikasini aks ettiradi, bunda 0.00 ko'rsatkichi ushbu darajani belgilaydi. Barqarorlik shifoxona asosidagi Markaziy Nerv Tizimi (CNS) inyeksiyalarini ishlab chiqish, kam uchraydigan miya patologiyalariga e'tibor qaratish va patent muddatining tugashi risklarini minimallashtiruvchi mustaqil sinov dasturlari mavjudligi orqali ta'minlanmoqda.

Narxning kelajakdagi foydaga nisbati: Avenue Therapeutics Inc. (ATXI) 04.07.2022 - 29.03.2025 uchun

Avenue Therapeutics, Inc. (ATXI) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Fundamental baholash:Avenue Therapeutics, Inc. ATXI
avenuetx.com brendining mahsuloti

Nevrologik dori vositalari uchun ishlab chiqarish zanjirlarini optimallashtirish Avenue Therapeutics (ATXI) kompaniyasiga barqaror marjalar va bashorat qilinadigan operatsion xarajatlarni ta'minlaydi. Kompaniyaning kelajakdagi P/E koeffitsiyenti tahlili joriy bozor kapitalizatsiyasi va prognoz qilingan sof foyda o'rtasidagi korrelyatsiyani aniqlash imkonini beradi, bu esa kelajakdagi klinik sinovlar muvaffaqiyatlari uchun to'langan premiumni belgilaydi va biznesning baholanishi bo'yicha uzoq muddatli investorlar konsensusini shakllantiradi.

Muhim raqobatchilar

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forvard P/E multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Prognoz qilingan narxning foydaga nisbati|CRVO (CervoMed, Inc.) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alterity Therapeutics Ltd|Kelajakdagi narxning foydaga nisbati Clene Inc.|PepGen Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Kelajakdagi narxning foydaga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - Forvard P/E multiplikatori|Klotho Neurosciences (KLTO) - Prognoz qilingan narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. (NRSN) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forvard P/E multiplikatori|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori Passage Bio Inc. (PASG)|Kelajakdagi narxning foydaga nisbati bionomics.com.au NEUP|Forvard P/E multiplikatori Minerva Neurosciences Inc NERV|ATHA: Prognoz qilingan narxning foydaga nisbati|ADXN (Addex Therapeutics, Ltd.) - Narxning kelajakdagi foydaga nisbati|Alzamend Neuro Inc. (ALZN) - Kelajakdagi narxning foydaga nisbati|Cyclerion - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati protagenic.com|Pasithea Therapeutics - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati CRGT (Cortigent, Inc.)|BCLI - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Prognoz qilingan narxning foydaga nisbati|ELYM: Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)